Results 181 to 190 of about 47,697 (254)

Spatial transcriptomics mapping of immune cell and TGFβ signalling pathway heterogeneity in testicular germ cell tumours

open access: yesAndrology, Volume 14, Issue 1, Page 210-227, January 2026.
Abstract Background Testicular germ cell tumours (TGCTs) are amongst the most common malignancies in young men, and their incidence is increasing worldwide. Tissue heterogeneity hampers efforts to understand how TGCT precursors (termed germ cell neoplasia in situ; GCNIS) emerge and progress, restricting elucidation of new strategies for diagnosis and ...
Sarah C. Moody   +6 more
wiley   +1 more source

Optimization of Nile Tilapia Artificial Breeding Using Human Chorionic Gonadotropin (hCG) Hormone. [PDF]

open access: yesMethods Protoc
Rbbani G   +6 more
europepmc   +1 more source

Objective and comprehensive characterization of uterine peristaltic activity throughout the menstrual cycle by means of intracavitary electrohysterography, a cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 1, Page 156-165, January 2026.
Phase and regional dependent patterns of uterine peristaltic features have been identified and comprehensively characterized, providing reference values of fertile conditions. Abstract Introduction The uterus exhibits dynamic peristaltic activity across the menstrual cycle, playing a critical role in reproductive processes such as sperm transport and ...
Jose Alberola‐Rubio   +8 more
wiley   +1 more source

Endometrial carcinoma with ectopic human chorionic gonadotropin expression

open access: yesGynecologic Oncology Reports, 2015
Regina Lee   +4 more
doaj   +1 more source

Development of molecularly imprinted polymers for the detection of human chorionic gonadotropin. [PDF]

open access: yesSci Rep
Zubrytė R   +10 more
europepmc   +1 more source

An immunohistochemical study of hepatoblastoma producing human chorionic gonadotropin [PDF]

open access: bronze, 1983
Shojiroh Morinaga   +5 more
openalex   +1 more source

Assessment of new prognostic risk models for recurrence in patients with clinical stage I seminoma

open access: yesBJU International, Volume 137, Issue 1, Page 138-145, January 2026.
Objectives To evaluate two new prognostic risk models aimed at improving clinical decision‐making in patients with clinical stage (cS) I seminomatous testicular germ cell tumours (GCTs), 5%–30% of whom experience recurrence during surveillance after orchiectomy and may benefit from adjuvant therapy.
Angelina Strauch   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy